These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value? Albrecht K, Uckert S, Oelke M, Andersson KE, Jonas U, Tröger HD, Hedlund P. J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813 [Abstract] [Full Text] [Related]
4. Vardenafil enhances clitoral and vaginal blood flow responses to pelvic nerve stimulation in female dogs. Angulo J, Cuevas P, Cuevas B, Bischoff E, Sáenz de Tejada I. Int J Impot Res; 2003 Apr; 15(2):137-41. PubMed ID: 12789394 [Abstract] [Full Text] [Related]
5. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Park K, Moreland RB, Goldstein I, Atala A, Traish A. Biochem Biophys Res Commun; 1998 Aug 28; 249(3):612-7. PubMed ID: 9731184 [Abstract] [Full Text] [Related]
6. Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5). Ückert S, Oelke M, Albrecht K, Breitmeier D, Kuczyk MA, Hedlund P. Int J Impot Res; 2011 Aug 28; 23(5):206-12. PubMed ID: 21697861 [Abstract] [Full Text] [Related]
7. Expressions of vaginal endothelial nitric oxide synthase and phosphodiesterase 5 in female sexual dysfunction: a pilot study. Cho KJ, Lee KS, Choo MS, Seo JT, Kim JH, Choi JB, Oh SJ, Kim JC. Int Urogynecol J; 2017 Mar 28; 28(3):431-436. PubMed ID: 27686568 [Abstract] [Full Text] [Related]
8. The role of regulatory proteins and S-nitrosylation of endothelial nitric oxide synthase in the human clitoris: implications for female sexual function. Oliver JL, Kavoussi PK, Smith RP, Woodson RI, Corbett ST, Costabile RA, Palmer LA, Lysiak JJ. J Sex Med; 2014 Aug 28; 11(8):1927-35. PubMed ID: 24836757 [Abstract] [Full Text] [Related]
9. Cyclic adenosine monophosphate and cyclic guanosine monophosphate-phosphodiesterase isoenzymes in human vagina: relation to nitric oxide synthase isoforms and vasoactive intestinal polypeptide-containing nerves. Uckert S, Oelke M, Waldkirch E, Stief CG, Albrecht K, Tröger HD, Jonas U, Andersson KE, Hedlund P. Urology; 2005 Mar 28; 65(3):604-10. PubMed ID: 15780401 [Abstract] [Full Text] [Related]
10. Functional anatomy of the human vagina. D'Amati G, di Gioia CR, Proietti Pannunzi L, Pistilli D, Carosa E, Lenzi A, Jannini EA. J Endocrinol Invest; 2003 Mar 28; 26(3 Suppl):92-6. PubMed ID: 12834030 [Abstract] [Full Text] [Related]
11. Inhibition of phosphodiesterase 4 enhances clitoral and vaginal blood flow responses to dorsal clitoral nerve stimulation or PGE1 in anesthetized female rats. Castiglione F, Bergamini A, Russo A, La Croce G, Castagna G, Colciago G, Salonia A, Rigatti P, Montorsi F, Hedlund P. J Sex Med; 2013 Apr 28; 10(4):939-50. PubMed ID: 23347325 [Abstract] [Full Text] [Related]
12. Phosphodiesterase type 1, calcitonin gene-related peptide and vasoactive intestinal polypeptide are involved in the control of human vaginal arterial vessels. Uckert S, Albrecht K, Kuczyk MA, Hedlund P, Oelke M. Eur J Obstet Gynecol Reprod Biol; 2013 Jul 28; 169(2):283-6. PubMed ID: 23490535 [Abstract] [Full Text] [Related]
13. Experimental models for the investigation of female sexual function and dysfunction. Min K, O'Connell L, Munarriz R, Huang YH, Choi S, Kim N, Goldstein I, Traish A. Int J Impot Res; 2001 Jun 28; 13(3):151-6. PubMed ID: 11525313 [Abstract] [Full Text] [Related]
14. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Wharton J, Strange JW, Møller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR. Am J Respir Crit Care Med; 2005 Jul 01; 172(1):105-13. PubMed ID: 15817798 [Abstract] [Full Text] [Related]
16. Effects of estrogen on nitric oxide synthase and histological composition in the rabbit clitoris and vagina. Yoon HN, Chung WS, Park YY, Shim BS, Han WS, Kwon SW. Int J Impot Res; 2001 Aug 01; 13(4):205-11. PubMed ID: 11494077 [Abstract] [Full Text] [Related]
17. Phosphodiesterase 5 mechanisms and therapeutic applications. Burnett AL. Am J Cardiol; 2005 Dec 26; 96(12B):29M-31M. PubMed ID: 16387563 [Abstract] [Full Text] [Related]
18. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Corbin JD, Francis SH, Webb DJ. Urology; 2002 Sep 26; 60(2 Suppl 2):4-11. PubMed ID: 12414329 [Abstract] [Full Text] [Related]